Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASM-024 in moderate to severe COPD
NCT01855230Phase 2Completed
- Sponsor
- Asmacure Ltée
- Start
- Aug 2013
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of asm-024 in chronic obstructive pulmonary disease (COPD), sponsored by Asmacure Ltée. Started Aug 2013; status: completed.
02
Drugs
asm-024
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01855230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01855230.